Spelling suggestions: "subject:"river cancer"" "subject:"river devancer""
141 |
Risk and Predictive Factors for Liver Cancer : Analysis of Data from a Cohort StudySookthai, Disorn January 2011 (has links)
The association between the risk of liver cancer and blood chemistry was investigated in a cohort study with 95,150 men and women from two counties in Sweden. In 1963-65, blood tests and physical measurements were undertaken. All individuals were then followed up until 2007, and a total of 312 were diagnosed with liver cancer. Using survival analysis and logistic regression, significant risk factors were identified. Stepwise Cox proportional hazards regression applied to a main effect model revealed that Glutamic Pyruvate Transaminase (GPT) and Thymol Turbidity (TYM) were the most significant risk factors (p<0.0001), followed by Protein-Bound Hexoses (HEX) (p=0.002), sex (p=0.02), and Serum Iron (p= 0.03). Increasing the level of GPT expressed in U/L from normal (<21) to slightly elevated (21, 31) or substantially elevated (>31) raised the hazard of experiencing liver cancer by a factor of 1.45 and 4.09, respectively. In addition, GPT was found to be the most significant risk factor in almost all age groups among both men and women. However, there was no evidence that elevated GPT levels within the normal range (<21), influenced the risk of liver cancer. Additional subgroup analyses revealed that TYM was highly significant within the group with normal GPT, and a high level of HEX (≥134 mg/dl) increased the hazard 1.55 times in comparison with the lowest HEX group (<115 mg/dl). BMI was significant only in the male subgroup (p<0.01) and, in the obesity group, the hazard of experiencing liver cancer was 1.99 times higher than in the normal BMI group. A significant three-way interaction between GPT, BMI and gender was present (p=0.05) with a robust significant two-way interaction between GPT and BMI (p<0.01) in the male subgroup.
|
142 |
Epigenetic regulation of gene expression of cystatin 6, CST6, in hepatocellular carcinomaMa, Ka-li, Marcella, 馬嘉莉 January 2005 (has links)
published_or_final_version / Medical Sciences / Master / Master of Medical Sciences
|
143 |
Dual-tracer positron emission tomography in the evaluation ofprimary & metastatic hepatocellular carcinomaHo, Chi-lai., 何志禮. January 2010 (has links)
published_or_final_version / Medicine / Master / Doctor of Medicine
|
144 |
Nucleocytoplasmic shuttling of Smad7 that plays paradoxical roles in hepatocellular carcinomaKong, Pui-ching, Christie, 高佩卿. January 2010 (has links)
published_or_final_version / Surgery / Master / Master of Philosophy
|
145 |
The interaction of mortalin and p53 in human hepatocellular carcinomaLu, Wenjing, 鲁文静 January 2011 (has links)
published_or_final_version / Surgery / Doctoral / Doctor of Philosophy
|
146 |
The potential applications of AMPK activator resveratrol and PAK1 inhibitor IPA-3 in cancer therapyWong, Yuk-na, 王玉娜 January 2010 (has links)
published_or_final_version / Anatomy / Master / Master of Philosophy
|
147 |
Identification of miR-106b over-expression in metastatic hepatocellular carcinoma by using the orthotopic animal modelYau, Wing-lung., 邱泳龍. January 2010 (has links)
published_or_final_version / Surgery / Doctoral / Doctor of Philosophy
|
148 |
Expression of met receptor tyrosine kinase in hepatocellularcarcinomaCheung, Man-ting., 張敏婷. January 2011 (has links)
published_or_final_version / Pathology / Master / Master of Medical Sciences
|
149 |
Interleukin 17A and interleukin 23 in chronic hepatitis B and hepatocellular carcinomaLi, Jian, 李健 January 2011 (has links)
published_or_final_version / Clinical Oncology / Doctoral / Doctor of Philosophy
|
150 |
A systematic review of the drug sorafenib in extending survival time in patients with hepatocellular carcinomaWong, Carmen, 黃嘉敏 January 2011 (has links)
published_or_final_version / Public Health / Master / Master of Public Health
|
Page generated in 0.067 seconds